Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Tubuloids derived from human adult kidney and urine for personalized disease modeling.

Schutgens F, Rookmaaker MB, Margaritis T, Rios A, Ammerlaan C, Jansen J, Gijzen L, Vormann M, Vonk A, Viveen M, Yengej FY, Derakhshan S, de Winter-de Groot KM, Artegiani B, van Boxtel R, Cuppen E, Hendrickx APA, van den Heuvel-Eibrink MM, Heitzer E, Lanz H, Beekman J, Murk JL, Masereeuw R, Holstege F, Drost J, Verhaar MC, Clevers H.

Nat Biotechnol. 2019 Mar;37(3):303-313. doi: 10.1038/s41587-019-0048-8. Epub 2019 Mar 4.

PMID:
30833775
2.

Histological characteristics of Acute Tubular Injury during Delayed Graft Function predict renal function after renal transplantation.

Pieters TT, Falke LL, Nguyen TQ, Verhaar MC, Florquin S, Bemelman FJ, Kers J, Vanhove T, Kuypers D, Goldschmeding R, Rookmaaker MB.

Physiol Rep. 2019 Mar;7(5):e14000. doi: 10.14814/phy2.14000.

3.

Effect of donor variation on osteogenesis and vasculogenesis in hydrogel cocultures.

Pennings I, van Dijk LA, van Huuksloot J, Fledderus JO, Schepers K, Braat AK, Hsiao EC, Barruet E, Morales BM, Verhaar MC, Rosenberg AJWP, Gawlitta D.

J Tissue Eng Regen Med. 2019 Jan 16. doi: 10.1002/term.2807. [Epub ahead of print]

PMID:
30650247
4.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

5.

Performance of bleeding risk scores in dialysis patients.

Ocak G, Ramspek C, Rookmaaker MB, Blankestijn PJ, Verhaar MC, Bos WJW, Dekker FW, van Diepen M.

Nephrol Dial Transplant. 2019 Jan 4. doi: 10.1093/ndt/gfy387. [Epub ahead of print]

PMID:
30608543
6.

Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.

Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.

Nephrol Dial Transplant. 2018 Dec 15. doi: 10.1093/ndt/gfy377. [Epub ahead of print]

PMID:
30561730
7.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
8.

Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis.

Vervoort SJ, de Jong OG, Roukens MG, Frederiks CL, Vermeulen JF, Lourenço AR, Bella L, Vidakovic AT, Sandoval JL, Moelans C, van Amersfoort M, Dallman MJ, Bruna A, Caldas C, Nieuwenhuis E, van der Wall E, Derksen P, van Diest P, Verhaar MC, Lam EW, Mokry M, Coffer PJ.

Elife. 2018 Dec 3;7. pii: e27706. doi: 10.7554/eLife.27706.

9.

Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis.

Jansz TT, van Reekum FE, Özyilmaz A, de Jong PA, Boereboom FTJ, Hoekstra T, Verhaar MC, van Jaarsveld BC.

Am J Nephrol. 2018;48(5):369-377. doi: 10.1159/000494665. Epub 2018 Nov 13.

10.

Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.

de Jong OG, van der Waals LM, Kools FRW, Verhaar MC, van Balkom BWM.

J Cell Physiol. 2019 Jul;234(7):10260-10269. doi: 10.1002/jcp.27695. Epub 2018 Nov 1.

PMID:
30387148
11.

Geriatric Assessment in Elderly Patients with End-Stage Kidney Disease.

Goto NA, van Loon IN, Morpey MI, Verhaar MC, Willems HC, Emmelot-Vonk MH, Bots ML, Boereboom FTJ, Hamaker ME.

Nephron. 2019;141(1):41-48. doi: 10.1159/000494222. Epub 2018 Nov 1.

12.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2018 Oct 25. doi: 10.1093/ndt/gfy316. [Epub ahead of print]

PMID:
30365008
13.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
14.

Accidental falling in community-dwelling elderly with chronic kidney disease.

Goto NA, Hamaker ME, Willems HC, Verhaar MC, Emmelot-Vonk MH.

Int Urol Nephrol. 2019 Jan;51(1):119-127. doi: 10.1007/s11255-018-1992-9. Epub 2018 Oct 15.

15.

Health-related quality of life compared between kidney transplantation and nocturnal hemodialysis.

Jansz TT, Bonenkamp AA, Boereboom FTJ, van Reekum FE, Verhaar MC, van Jaarsveld BC.

PLoS One. 2018 Sep 20;13(9):e0204405. doi: 10.1371/journal.pone.0204405. eCollection 2018.

16.

Bioengineering Organs for Blood Detoxification.

Legallais C, Kim D, Mihaila SM, Mihajlovic M, Figliuzzi M, Bonandrini B, Salerno S, Yousef Yengej FA, Rookmaaker MB, Sanchez Romero N, Sainz-Arnal P, Pereira U, Pasqua M, Gerritsen KGF, Verhaar MC, Remuzzi A, Baptista PM, De Bartolo L, Masereeuw R, Stamatialis D.

Adv Healthc Mater. 2018 Nov;7(21):e1800430. doi: 10.1002/adhm.201800430. Epub 2018 Sep 19. Review.

PMID:
30230709
17.

The role of kidney transplantation and phosphate binder use in vitamin K status.

Jansz TT, Neradova A, van Ballegooijen AJ, Verhaar MC, Vervloet MG, Schurgers LJ, van Jaarsveld BC.

PLoS One. 2018 Aug 30;13(8):e0203157. doi: 10.1371/journal.pone.0203157. eCollection 2018.

18.

A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol.

van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Schuurman AH, Bonte-Mineur F, Vonk MC, Voskuyl AE, de Vries-Bouwstra JK, Coert JH, Radstake TRDJ, van Laar JM, Verhaar MC; MANUS Study Group.

BMJ Open. 2018 Aug 20;8(8):e020479. doi: 10.1136/bmjopen-2017-020479.

19.

Toward a sensible single antigen bead cut-off based on kidney graft survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy JNM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2018 Aug 13. doi: 10.1097/TP.0000000000002357. [Epub ahead of print]

PMID:
30106794
20.

CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions.

Chrifi I, Louzao-Martinez L, Brandt MM, van Dijk CGM, Bürgisser PE, Zhu C, Kros JM, Verhaar MC, Duncker DJ, Cheng C.

Angiogenesis. 2019 Feb;22(1):75-93. doi: 10.1007/s10456-018-9638-1. Epub 2018 Aug 10.

PMID:
30097810
21.

Cell Therapy for Chronic Limb-Threatening Ischemia: Current Evidence and Future Directions.

Teraa M, Gremmels H, Wijnand JGJ, Verhaar MC.

Stem Cells Transl Med. 2018 Dec;7(12):842-846. doi: 10.1002/sctm.18-0025. Epub 2018 Aug 1.

22.

Mortality due to bleeding, myocardial infarction and stroke in dialysis patients.

Ocak G, Noordzij M, Rookmaaker MB, Cases A, Couchoud C, Heaf JG, Jarraya F, De Meester J, Groothoff JW, Waldum-Grevbo BE, Palsson R, Resic H, Remón C, Finne P, Stendahl M, Verhaar MC, Massy ZA, Dekker FW, Jager KJ.

J Thromb Haemost. 2018 Oct;16(10):1953-1963. doi: 10.1111/jth.14254. Epub 2018 Aug 22.

PMID:
30063819
23.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

PMID:
30049681
24.

Dissecting recipient from donor contribution in experimental kidney transplantation: focus on endothelial proliferation and inflammation.

Papazova DA, Krebber MM, Oosterhuis NR, Gremmels H, van Zuilen AD, Joles JA, Verhaar MC.

Dis Model Mech. 2018 Jul 17;11(7). pii: dmm035030. doi: 10.1242/dmm.035030.

25.

Removal of urea by electro-oxidation in a miniature dialysis device: a study in awake goats.

Wester M, van Gelder MK, Joles JA, Simonis F, Hazenbrink DHM, van Berkel TWM, Vaessen KRD, Boer WH, Verhaar MC, Gerritsen KGF.

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1385-F1397. doi: 10.1152/ajprenal.00094.2018. Epub 2018 Jul 11.

PMID:
29993277
26.

Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review.

Jansz TT, Verhaar MC, London GM, van Jaarsveld BC.

Clin Kidney J. 2018 Jun;11(3):353-361. doi: 10.1093/ckj/sfx124. Epub 2017 Oct 26.

27.

Mesenchymal Stromal Cell Characteristics and Regenerative Potential in Cardiovascular Disease: Implications for Cellular Therapy.

van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Verhaar MC.

Cell Transplant. 2018 May;27(5):765-785. doi: 10.1177/0963689717738257. Epub 2018 Jun 13.

28.

Vitamin K antagonist use and renal function in pre-dialysis patients.

Voskamp PW, Dekker FW, Rookmaaker MB, Verhaar MC, Bos WJW, van Diepen M, Ocak G.

Clin Epidemiol. 2018 May 29;10:623-630. doi: 10.2147/CLEP.S154719. eCollection 2018.

29.

Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.

Michielsen LA, van Zuilen AD, Kardol-Hoefnagel T, Verhaar MC, Otten HG.

Front Immunol. 2018 May 14;9:972. doi: 10.3389/fimmu.2018.00972. eCollection 2018.

30.

Endothelial loss of Fzd5 stimulates PKC/Ets1-mediated transcription of Angpt2 and Flt1.

Brandt MM, van Dijk CGM, Chrifi I, Kool HM, Bürgisser PE, Louzao-Martinez L, Pei J, Rottier RJ, Verhaar MC, Duncker DJ, Cheng C.

Angiogenesis. 2018 Nov;21(4):805-821. doi: 10.1007/s10456-018-9625-6. Epub 2018 May 29.

31.

Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.

van Haelst STW, Teraa M, Moll FL, de Borst GJ, Verhaar MC, Conte MS.

J Vasc Surg. 2018 Oct;68(4):1104-1113.e1. doi: 10.1016/j.jvs.2018.02.028. Epub 2018 May 22.

PMID:
29802042
32.

From portable dialysis to a bioengineered kidney.

van Gelder MK, Mihaila SM, Jansen J, Wester M, Verhaar MC, Joles JA, Stamatialis D, Masereeuw R, Gerritsen KGF.

Expert Rev Med Devices. 2018 May;15(5):323-336. doi: 10.1080/17434440.2018.1462697. Epub 2018 Apr 20. Review.

PMID:
29633900
33.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

34.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

35.

Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening.

Sorop O, Heinonen I, van Kranenburg M, van de Wouw J, de Beer VJ, Nguyen ITN, Octavia Y, van Duin RWB, Stam K, van Geuns RJ, Wielopolski PA, Krestin GP, van den Meiracker AH, Verjans R, van Bilsen M, Danser AHJ, Paulus WJ, Cheng C, Linke WA, Joles JA, Verhaar MC, van der Velden J, Merkus D, Duncker DJ.

Cardiovasc Res. 2018 Jun 1;114(7):954-964. doi: 10.1093/cvr/cvy038.

36.

Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation.

Michielsen LA, Budding K, Drop D, van de Graaf EA, Kardol-Hoefnagel T, Verhaar MC, van Zuilen AD, Otten HG.

Front Immunol. 2018 Jan 22;8:2008. doi: 10.3389/fimmu.2017.02008. eCollection 2017.

37.

High and immeasurable ankle-brachial index as predictor of poor amputation-free survival in critical limb ischemia.

Spreen MI, Gremmels H, Teraa M, Sprengers RW, Martens JM, Verhaar MC, Wever JJ, de Borst GJ, Vos JA, Mali WPTM, van Overhagen H; PADI and JUVENTAS trial groups.

J Vasc Surg. 2018 Jun;67(6):1864-1871.e3. doi: 10.1016/j.jvs.2017.10.061. Epub 2017 Dec 28.

PMID:
29290494
38.

Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia.

Wijnand JGJ, Teraa M, Gremmels H, van Rhijn-Brouwer FCC, de Borst GJ, Verhaar MC; SAIL Study Group.

J Vasc Surg. 2018 Feb;67(2):656-661. doi: 10.1016/j.jvs.2017.09.026. Epub 2017 Dec 11.

PMID:
29242062
39.

Troy/TNFRSF19 marks epithelial progenitor cells during mouse kidney development that continue to contribute to turnover in adult kidney.

Schutgens F, Rookmaaker MB, Blokzijl F, van Boxtel R, Vries R, Cuppen E, Verhaar MC, Clevers H.

Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11190-E11198. doi: 10.1073/pnas.1714145115. Epub 2017 Dec 13.

40.

Association of Whole Blood Tacrolimus Concentrations with Kidney Injury in Heart Transplantation Patients.

Sikma MA, Hunault CC, Kirkels JH, Verhaar MC, Kesecioglu J, de Lange DW.

Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):311-320. doi: 10.1007/s13318-017-0453-7.

41.

Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study.

Ocak G, Rookmaaker MB, Algra A, de Borst GJ, Doevendans PA, Kappelle LJ, Verhaar MC, Visseren FL; SMART Study Group.

J Thromb Haemost. 2018 Jan;16(1):65-73. doi: 10.1111/jth.13904. Epub 2017 Dec 20.

PMID:
29125709
42.

Chromatin Conformation Links Distal Target Genes to CKD Loci.

Brandt MM, Meddens CA, Louzao-Martinez L, van den Dungen NAM, Lansu NR, Nieuwenhuis EES, Duncker DJ, Verhaar MC, Joles JA, Mokry M, Cheng C.

J Am Soc Nephrol. 2018 Feb;29(2):462-476. doi: 10.1681/ASN.2016080875. Epub 2017 Nov 1.

43.

Vitamin K antagonist use and mortality in dialysis patients.

Voskamp PWM, Rookmaaker MB, Verhaar MC, Dekker FW, Ocak G.

Nephrol Dial Transplant. 2018 Jan 1;33(1):170-176. doi: 10.1093/ndt/gfx199.

PMID:
28992189
44.

Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease.

De Haan JJ, Haitjema S, den Ruijter HM, Pasterkamp G, de Borst GJ, Teraa M, Verhaar MC, Gremmels H, de Jager SCA.

J Am Heart Assoc. 2017 Aug 30;6(9). pii: e006225. doi: 10.1161/JAHA.117.006225.

45.

Frailty Screening Tools for Elderly Patients Incident to Dialysis.

van Loon IN, Goto NA, Boereboom FTJ, Bots ML, Verhaar MC, Hamaker ME.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1480-1488. doi: 10.2215/CJN.11801116. Epub 2017 Jul 17.

46.

Quality of life as indicator of poor outcome in hemodialysis: relation with mortality in different age groups.

van Loon IN, Bots ML, Boereboom FTJ, Grooteman MPC, Blankestijn PJ, van den Dorpel MA, Nubé MJ, Ter Wee PM, Verhaar MC, Hamaker ME.

BMC Nephrol. 2017 Jul 6;18(1):217. doi: 10.1186/s12882-017-0621-7.

47.

The Transcription Factor Nrf2 Protects Angiogenic Capacity of Endothelial Colony-Forming Cells in High-Oxygen Radical Stress Conditions.

Gremmels H, de Jong OG, Hazenbrink DH, Fledderus JO, Verhaar MC.

Stem Cells Int. 2017;2017:4680612. doi: 10.1155/2017/4680612. Epub 2017 May 15.

48.

Innovative Perspective: Gadolinium-Free Magnetic Resonance Imaging in Long-Term Follow-Up after Kidney Transplantation.

van Eijs MJM, van Zuilen AD, de Boer A, Froeling M, Nguyen TQ, Joles JA, Leiner T, Verhaar MC.

Front Physiol. 2017 May 16;8:296. doi: 10.3389/fphys.2017.00296. eCollection 2017. Review.

49.

T-cells contribute to hypertension but not to renal injury in mice with subtotal nephrectomy.

Oosterhuis NR, Papazova DA, Gremmels H, Joles JA, Verhaar MC.

BMC Nephrol. 2017 May 8;18(1):153. doi: 10.1186/s12882-017-0555-0.

50.

Proteins in Preservation Fluid as Predictors of Delayed Graft Function in Kidneys from Donors after Circulatory Death.

van Balkom BWM, Gremmels H, Ooms LSS, Toorop RJ, Dor FJMF, de Jong OG, Michielsen LA, de Borst GJ, de Jager W, Abrahams AC, van Zuilen AD, Verhaar MC.

Clin J Am Soc Nephrol. 2017 May 8;12(5):817-824. doi: 10.2215/CJN.10701016.

Supplemental Content

Loading ...
Support Center